Connect with Quotient Sciences at the upcoming CPhI North America in Philadelphia, Pa from May 17-19. Our drug substance & drug product experts will be on hand in booth 1505 to discuss your drug development needs and update you on our expanded capabilities.
Our subject matter experts in attendance include:
Dr Aruna Railkar- Sr. Drug Development Consultant (Drug Product & Integrated Programs)
Dr Stephen McQuaker - Sr. Drug Development Consultant (Drug Substance & Candidate Development)
To schedule a meeting with Aruna and/or Stephen at the event, email: firstname.lastname@example.org
CPhI Lunch Seminar on May 18th - "Moving Drug Substance Off the Critical Path- Streamlined Strategies to Accelerate to First-in-Human & Beyond"
We will also be hosting a complimentary lunch and learn seminar on Wednesday, May 18th from 12-1pm at the Loews Philadelphia Hotel entitled: "Moving Drug Substance Off the Critical Path- Streamlined Strategies to Accelerate to First-in-Human & Beyond". In this presentation, Quotient's Director of Drug Development Consulting, Dr Stephen McQuaker, will discuss the different routes that drug developers can take to synthesize and manufacture their drug substance and evaluate their pros and cons. He will share how integrated drug substance and drug product capabilities in the candidate selection stage can aid in selecting the best molecules to move forward with into drug substance and beyond. He will also touch on the key technologies that can be employed to establish a robust, and commercially scalable synthetic process. Using case studies, he will demonstrate how drug substance and drug product development plans can be accelerated through innovative science and expertise in order to help you get your program’s drug substance off the critical path.
For more information of to register visit: https://www.quotientsciences.com/events/cphi-na-lunch-seminar-moving-drug-substance-critical-path/
Event: CPhI North Amercia
Date: May 17-19, 2022
Location: Philadelphia, PA
Conference Website: https://bit.ly/3o1Az2P